汎ぶどう膜炎の世界市場レポート 2025年

汎ぶどう膜炎市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.2％で65億8,000万米ドルに成長します。予測期間の成長は、生物学的療法の使用拡大、個別化医療に対する需要の増加、ぶどう膜炎に関連する疾患の有病率の上昇、眼科研究に対する投資の増加、疾患に対する意識の高まりに起因すると考えられます。この期間に予想される主要動向には、生物学的療法の採用拡大、徐放性ドラッグデリバリーシステムの開発、個別化医療アプローチの拡大、AIを活用した診断・治療の進歩、低侵襲手術技術の台頭などがあります。

自己免疫疾患の有病率の増加は、今後数年間の汎ぶどう膜炎市場の成長を促進すると予想されます。自己免疫疾患は、免疫系が誤って身体の健康な細胞や組織を攻撃することで発生します。このような有病率の上昇は、遺伝的素因、汚染や食生活の変化などの環境的影響、免疫系調節不全の引き金となる感染症やストレス要因へのさらなる暴露などの要因に起因しています。自己免疫疾患は、多くの汎ぶどう膜炎症例が自己免疫活動に関連していることから、免疫系調節の研究を促進することによって汎ぶどう膜炎治療を前進させています。例えば、2023年5月、英国の研究機関であるオックスFord大学は、自己免疫疾患が世界人口の10％に影響を及ぼし、女性の13％、男性の7％が影響を受けていると報告しました。その結果、自己免疫疾患の発生が増加しており、汎ぶどう膜炎市場の拡大に拍車をかけています。

汎ぶどう膜炎市場の主要企業は、患者のコンプライアンスと治療効果を高めるため、先進的な徐放性硝子体内注射製剤の開発を優先しています。徐放性硝子体内注射製剤は、薬剤を長期間にわたって徐々に眼球の硝子体液中に投与するドラッグデリバリーシステムであり、頻繁な投与の必要性を最小限に抑えながら治療効果を持続させています。例えば、2022年8月、イスラエルを拠点とする臨床段階の企業であるTarsier Pharmaは、網膜疾患治療のための潜在的な免疫調節薬であるTRS02の開発を発表しました。この革新的な治療は、後部ぶどう膜炎（汎ぶどう膜炎）や糖尿病性黄斑浮腫など、炎症性病態を伴う様々な目の奥の疾患に対応するようデザインされています。TRS02はTarsier独自の技術プラットフォームを使用して開発され、前臨床検査でのマイルストーンに成功した後、治験薬（IND）申請に向けて前進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の汎ぶどう膜炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の汎ぶどう膜炎市場：成長率分析
• 世界の汎ぶどう膜炎市場の実績：規模と成長、2019～2024年
• 世界の汎ぶどう膜炎市場の予測：規模と成長、2024～2029年、2034年
• 世界の汎ぶどう膜炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の汎ぶどう膜炎市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 感染性汎ぶどう膜炎
• 非感染性汎ぶどう膜炎
• 世界の汎ぶどう膜炎市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬理学
• 外科手術
• 光線療法
• 世界の汎ぶどう膜炎市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 硝子体内
• 局所
• 世界の汎ぶどう膜炎市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の汎ぶどう膜炎市場、感染性全ぶどう膜炎のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 細菌汎ぶどう膜炎
• バイラル汎ぶどう膜炎
• 真菌の汎ぶどう膜炎
• 寄生的汎ぶどう膜炎
• 世界の汎ぶどう膜炎市場、非感染性全ぶどう膜炎のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 自己免疫関連汎ぶどう膜炎
• 特発性汎ぶどう膜炎
• 薬剤誘発性汎ぶどう膜炎

第7章 地域別・国別分析

• 世界の汎ぶどう膜炎市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の汎ぶどう膜炎市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 汎ぶどう膜炎市場：競合情勢
• 汎ぶどう膜炎市場：企業プロファイル
  • Pfizer Inc.
  • AbbVie
  • Boehringer Ingelheim International GmbH
  • Amgen
  • Teva Pharmaceuticals

第31章 その他の大手企業と革新的企業

• Sandoz
• Organon group of companies
• Zydus Lifesciences Ltd.
• Mallinckrodt plc
• Alvotech
• EyePoint Pharmaceuticals Inc.
• Affibody Medical AB
• Alumis Inc.
• Fujifilm Kyowa Kirin Biologics Co. Ltd.
• Revolo BIoTherapeutics Ltd.
• Tarsier Pharma
• Priovant Therapeutics Inc.
• Mylan N.V.
• Clearside Biomedical Inc.
• pSivida Corp.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 汎ぶどう膜炎市場、2029年：新たな機会を提供する国
• 汎ぶどう膜炎市場、2029年：新たな機会を提供するセグメント
• 汎ぶどう膜炎市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Panuveitis is an inflammatory condition that affects all three layers of the uvea include the iris, ciliary body, and choroid within the eye. If left untreated, it can cause pain, blurred vision, and potentially lead to vision loss. The primary goal of treatment is to control inflammation, alleviate symptoms, and prevent further eye damage that could impair vision. Timely intervention is crucial for maintaining eye health and preserving sight.

The main types of panuveitis include infectious and non-infectious panuveitis. Infectious panuveitis is caused by infectious agents and requires prompt diagnosis and treatment to prevent severe eye complications and vision impairment. Treatment options include pharmacological therapy, surgical interventions, and phototherapy, administered via oral, intravitreal, and topical routes. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, ensuring accessibility for patients.

The panuveitis market research report is one of a series of new reports from The Business Research Company that provides panuveitis market statistics, including the panuveitis industry global market size, regional shares, competitors with the panuveitis market share, detailed panuveitis market segments, market trends, and opportunities, and any further data you may need to thrive in the panuveitis industry. This panuveitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The panuveitis market size has grown rapidly in recent years. It will grow from $4.05 billion in 2024 to $4.47 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the prevalence of autoimmune and infectious diseases, the increasing use of corticosteroids, the rising adoption of biologics, the growing demand for ophthalmic imaging, and expanding research investment in infectious causes.

The panuveitis market size is expected to see rapid growth in the next few years. It will grow to $6.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the expanding use of biologic therapies, increasing demand for personalized medicine, the rising prevalence of uveitis-linked diseases, higher investments in ophthalmic research, and growing disease awareness. Major trends expected during this period include the increasing adoption of biologic therapies, the development of sustained-release drug delivery systems, the expansion of personalized medicine approaches, advancements in AI-driven diagnosis and treatment, and the rise of minimally invasive surgical techniques.

The increasing prevalence of autoimmune disorders is expected to drive the growth of the panuveitis market in the coming years. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues. This rising prevalence is attributed to factors such as genetic predisposition, environmental influences such as pollution and dietary changes, and greater exposure to infections and stressors that can trigger immune system dysregulation. Autoimmune disorders are advancing panuveitis treatment by promoting research into immune system modulation, as many cases of panuveitis are linked to autoimmune activity. For instance, in May 2023, the University of Oxford, a UK-based research institution, reported that autoimmune disorders affect 10% of the global population, with 13% of women and 7% of men impacted. As a result, the increasing occurrence of autoimmune disorders is fueling the expansion of the panuveitis market.

Leading companies in the panuveitis market are prioritizing the development of advanced slow-release intravitreal injection formulations to enhance patient compliance and treatment effectiveness. A slow-release intravitreal injection formulation is a drug delivery system that gradually administers medication into the eye's vitreous humor over an extended period, ensuring sustained therapeutic effects while minimizing the need for frequent dosing. For example, in August 2022, Tarsier Pharma, an Israel-based clinical-stage company, announced the development of TRS02, a potential immunomodulator for the treatment of retinal diseases. This innovative therapy is designed to address various back-of-the-eye conditions with inflammatory pathologies, including posterior uveitis (panuveitis) and diabetic macular edema. TRS02, developed using Tarsier's proprietary technology platform, is advancing toward investigational new drug (IND) submission following successful preclinical milestones.

In July 2023, Harrow Health Inc., a US-based pharmaceutical company, acquired Santen Pharmaceutical Co., Ltd. for an undisclosed sum. This acquisition enables Harrow to expand its portfolio by integrating Santen's expertise in developing innovative treatments for uveitis and panuveitis. Santen Pharmaceutical Co. Ltd., a Japan-based company, specializes in treatments for panuveitis.

Major players in the panuveitis market are Pfizer Inc., AbbVie, Boehringer Ingelheim International GmbH, Amgen, Teva Pharmaceuticals, Sandoz, Organon group of companies, Zydus Lifesciences Ltd., Mallinckrodt plc, Alvotech, EyePoint Pharmaceuticals Inc., Affibody Medical AB, Alumis Inc., Fujifilm Kyowa Kirin Biologics Co. Ltd., Revolo Biotherapeutics Ltd., Tarsier Pharma, Priovant Therapeutics Inc., Mylan N.V., Clearside Biomedical Inc., pSivida Corp.

North America was the largest region in the panuveitis market in 2024. The regions covered in panuveitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the panuveitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The panuveitis market consists of revenues earned by entities providing services such as pharmaceutical treatment, surgical interventions, diagnostic services, and supportive care. The market value includes the value of related goods sold by the service providers or included within the service offering. The panuveitis market also includes sales of diagnostic tools, pharmaceuticals, biologic agents, immunosuppressive drugs, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Panuveitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on panuveitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for panuveitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panuveitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Infectious Panuveitis; Non-Infectious Panuveitis
• 2) By Treatment: Pharmacological; Surgical; Phototherapy
• 3) By Route Of Administration: Oral; Intravitreal; Topical
• 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• Subsegments:
• 1) By Infectious Panuveitis: Bacterial Panuveitis; Viral Panuveitis; Fungal Panuveitis; Parasitic Panuveitis
• 2) By Non-Infectious Panuveitis: Autoimmune-Related Panuveitis; Idiopathic Panuveitis; Drug-Induced Panuveitis
• Companies Mentioned:Pfizer Inc.; AbbVie; Boehringer Ingelheim International GmbH; Amgen; Teva Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Panuveitis Market Characteristics

3. Panuveitis Market Trends And Strategies

4. Panuveitis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Panuveitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Panuveitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Panuveitis Market Growth Rate Analysis
• 5.4. Global Panuveitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Panuveitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Panuveitis Total Addressable Market (TAM)

6. Panuveitis Market Segmentation

• 6.1. Global Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Panuveitis
• Non-Infectious Panuveitis
• 6.2. Global Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological
• Surgical
• Phototherapy
• 6.3. Global Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Intravitreal
• Topical
• 6.4. Global Panuveitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.5. Global Panuveitis Market, Sub-Segmentation Of Infectious Panuveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial Panuveitis
• Viral Panuveitis
• Fungal Panuveitis
• Parasitic Panuveitis
• 6.6. Global Panuveitis Market, Sub-Segmentation Of Non-Infectious Panuveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autoimmune-Related Panuveitis
• Idiopathic Panuveitis
• Drug-Induced Panuveitis

7. Panuveitis Market Regional And Country Analysis

• 7.1. Global Panuveitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Panuveitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Panuveitis Market

• 8.1. Asia-Pacific Panuveitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Panuveitis Market

• 9.1. China Panuveitis Market Overview
• 9.2. China Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Panuveitis Market

• 10.1. India Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Panuveitis Market

• 11.1. Japan Panuveitis Market Overview
• 11.2. Japan Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Panuveitis Market

• 12.1. Australia Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Panuveitis Market

• 13.1. Indonesia Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Panuveitis Market

• 14.1. South Korea Panuveitis Market Overview
• 14.2. South Korea Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Panuveitis Market

• 15.1. Western Europe Panuveitis Market Overview
• 15.2. Western Europe Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Panuveitis Market

• 16.1. UK Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Panuveitis Market

• 17.1. Germany Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Panuveitis Market

• 18.1. France Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Panuveitis Market

• 19.1. Italy Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Panuveitis Market

• 20.1. Spain Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Panuveitis Market

• 21.1. Eastern Europe Panuveitis Market Overview
• 21.2. Eastern Europe Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Panuveitis Market

• 22.1. Russia Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Panuveitis Market

• 23.1. North America Panuveitis Market Overview
• 23.2. North America Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Panuveitis Market

• 24.1. USA Panuveitis Market Overview
• 24.2. USA Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Panuveitis Market

• 25.1. Canada Panuveitis Market Overview
• 25.2. Canada Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Panuveitis Market

• 26.1. South America Panuveitis Market Overview
• 26.2. South America Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Panuveitis Market

• 27.1. Brazil Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Panuveitis Market

• 28.1. Middle East Panuveitis Market Overview
• 28.2. Middle East Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Panuveitis Market

• 29.1. Africa Panuveitis Market Overview
• 29.2. Africa Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Panuveitis Market Competitive Landscape And Company Profiles

• 30.1. Panuveitis Market Competitive Landscape
• 30.2. Panuveitis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Amgen Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Panuveitis Market Other Major And Innovative Companies

• 31.1. Sandoz
• 31.2. Organon group of companies
• 31.3. Zydus Lifesciences Ltd.
• 31.4. Mallinckrodt plc
• 31.5. Alvotech
• 31.6. EyePoint Pharmaceuticals Inc.
• 31.7. Affibody Medical AB
• 31.8. Alumis Inc.
• 31.9. Fujifilm Kyowa Kirin Biologics Co. Ltd.
• 31.10. Revolo Biotherapeutics Ltd.
• 31.11. Tarsier Pharma
• 31.12. Priovant Therapeutics Inc.
• 31.13. Mylan N.V.
• 31.14. Clearside Biomedical Inc.
• 31.15. pSivida Corp.

32. Global Panuveitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Panuveitis Market

34. Recent Developments In The Panuveitis Market

35. Panuveitis Market High Potential Countries, Segments and Strategies

• 35.1 Panuveitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Panuveitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Panuveitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer